0000919574-26-002294.txt : 20260417 0000919574-26-002294.hdr.sgml : 20260417 20260417163243 ACCESSION NUMBER: 0000919574-26-002294 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20260417 DATE AS OF CHANGE: 20260417 EFFECTIVENESS DATE: 20260417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zakara Biotechnology Fund Ltd. CENTRAL INDEX KEY: 0002064139 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-543717 FILM NUMBER: 26872056 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: C/O OGIER GLOBAL (CAYMAN) LTD STREET 2: 89 NEXUS WAY CITY: CAMANA BAY NON US STATE TERRITORY: CAYMAN ISLANDS PROVINCE COUNTRY: E9 ZIP: KY1-9009 BUSINESS PHONE: 1 646 419 8761 MAIL ADDRESS: STREET 1: 300 PARK AVENUE STREET 2: 2ND FLOOR CITY: CAMANA BAY STATE: NY ZIP: 10022 D/A 1 primary_doc.xml X0708 D/A LIVE 0002064139 Zakara Biotechnology Fund Ltd. C/O OGIER GLOBAL (CAYMAN) LTD 89 NEXUS WAY CAMANA BAY E9 CAYMAN ISLANDS KY1-9009 646 419 8761 CAYMAN ISLANDS None None Other Cayman Islands Exempted Company true 2025 - Zakara Capital LLC 300 Park Avenue 2nd Floor, Suite 201 New York NY NEW YORK 10022 Executive Officer Promoter Investment Manager Janet Okogbaa 300 Park Avenue 2nd Floor, Suite 201 New York NY NEW YORK 10022 Director Ekwutozia Nwabuzor 3 WTC, 175 Greenwich Street 55th Floor New York NY NEW YORK 10007 Director Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 true 0000919574-25-002460 2025-04-07 true true true false 100000 Indefinite 100000000 Indefinite false 1 0 true 0 true 0 true false Zakara Biotechnology Fund Ltd. /s/ Janet Okogbaa Janet Okogbaa Director 2026-04-17